Publication Beamlines Strategic Pillar
Allen, Meghan; Blyth, Rob; Cubbon, Grant; Ribeiro, Sandra; Weist, Erin et al. (2021). Operating the Canadian Light Source during the Pandemic: Safety, Innovations, and Perseverance. Synchrotron Radiation News 34(1-3) , 21-23. 10.1080/08940886.2021.1902720. SGM
Parashar, Abhinav; Gourgas, Ophélie; Lau, Kirk; Li, Jingjing; Muiznieks, Lisa et al. (2021). Elastin calcification in in vitro models and its prevention by MGP’s N-terminal peptide. Journal of Structural Biology 213(1) , 107637. 10.1016/j.jsb.2020.107637. SXRMB
Stark, Alison; Filice, Fraser; Noël, James J.; Martin, Ronald R.; Sham, Tsun-Kong et al. (2021). Retrieving Tarnished Daguerreotype Content Using X-ray Fluorescence Imaging—Recent Observations on the Effect of Chemical and Electrochemical Cleaning Methods. Heritage 4(3) , 1605-1615. 10.3390/heritage4030089. CLS-APS
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.